Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?
High phosphate intake is known to aggravate renal osteodystrophy along various pathogenetic pathways. Recent studies have raised the possibility that dysregulation of the osteocyte Wnt/β-catenin signaling pathway is also involved in chronic kidney disease (CKD)-related bone disease. We investigated...
Guardado en:
Autores principales: | Juliana C Ferreira, Guaraciaba O Ferrari, Katia R Neves, Raquel T Cavallari, Wagner V Dominguez, Luciene M Dos Reis, Fabiana G Graciolli, Elizabeth C Oliveira, Shiguang Liu, Yves Sabbagh, Vanda Jorgetti, Susan Schiavi, Rosa M A Moysés |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/781980599bad4e779c03aaa75fd55bd1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease
por: Daniel Cejka
Publicado: (2021) -
Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling.
por: Maarten van Dinther, et al.
Publicado: (2013) -
Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis
por: Elias S. Vasiliadis, et al.
Publicado: (2021) -
Kindlin-2 mediates mechanotransduction in bone by regulating expression of Sclerostin in osteocytes
por: Lei Qin, et al.
Publicado: (2021) -
Dietary Antioxidants and Metabolic Diseases
por: Alessandra Durazzo, et al.
Publicado: (2021)